Peripheral Neuropathy Trial, Recruiting NCT06104969 Sponsor: University of Michigan Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06104969
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to sign and date a consent form agreeing to take part.
  • People aged 18 years or older.
  • People who have been diagnosed with diabetes by a doctor, or whose test results meet the American Diabetes Association's criteria for diabetes.
  • People who have an open wound on the foot or ankle area (from the ankle bone downward), including wounds left open to heal after surgery in that area — if there are multiple wounds, the largest one would be used for the study.
  • People who are willing to attend all required study visits and provide the necessary samples and health information.

Who may not be able to join:

  • People who have taken part in another interventional clinical trial for diabetic foot ulcers within the past month before the first study visit.
  • People who are currently receiving radiation treatment or chemotherapy.
  • People who have gangrene (tissue death) anywhere on the foot that has the wound being studied.
  • People who are scheduled for, or currently being assessed for, a procedure to improve blood flow in the affected leg within the next 4 weeks of the study start.
  • People who have been assessed as having severely reduced blood flow to the limb (confirm with trial site for how this is measured).
  • People who have another medical or mental health condition that, in the opinion of the study doctors, could prevent them from safely completing the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 June 2023
Est. completion
15 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Wound Healing; DFU Infections; Amputations; Prediction Performance; Biospecimens Count; Biospecimen Quality; Standard of Care Prescription by Site; Standard of Care Adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov